|
The Concept
The Vaccines market in Asia is HUGE!
 The world vaccine revenue is growing at least 10% a year - from more than $11 billion this year to about $20 billion in 2012. Vaccines will outperform the wider pharmaceutical market, which is expected to grow about 7% a year.
Accompanied by the recent “take-off” of the Asian economy, a burgeoning and increasingly affluent middle class group of consumers are rapidly emerging. Their robust buying power is fueling the demand for an increased amount of high quality healthcare products. Unlike developed countries, Asia also covers the major epidemic areas for hepatitis, malaria, dengue and bird flu which requires specific vaccines developed for these diseases.
More than 3.6 billion people live in Asia, which is more than half of the world's population! Statistically, should only 5% of them demand for vaccines, this will equal to the whole market size of the United States.
Asia is set to become the world biggest market for Vaccines in the coming years!
Opportunities and challenges
The vaccines industry is no doubt at renaissance!
Currently, fears of a flu pandemic or a bioterrorist attack are fueling the increased political support for the vaccines industry. NGOs such as UNICEF, GAVI and Gates Foundation are also boosting philanthropic fundings for vaccines to improve world health. Meanwhile, breakthroughs in treating infectious diseases are also spurring the comeback of prospects for vaccine business.
In Asia, manufacturers from India, China, Indonesia and Korea etc have been upgrading their plant and aggressively expanding their global presence. However, the technology and quality gap, IP, financial and information barrier are limiting their growth.
Your show!
Many companies are seeing the potential and adapting their resources and technologies to fulfill the booming need of the Asian market. Competition is increasing for all producers but even more so for the suppliers of services, technology and products to the industry. The World Vaccine Congress Asia is your best opportunity to develop the relationships in Asia that make a difference to your business now and in the future!
This is a truly global platform and a world-class event gathering the world vaccines industry movers and shakers, who will deliver you the much needed opportunities to maintain and grow your market share.
Proven track record
-
Terrapinn, established in 1986, runs conferences on every continent
-
On average the World Vaccine Congress attracts over 70% Director / VP level attendees
-
Successful Pharma brands worldwide include: World Vaccine Congress Washington and Lyon; bioLOGIC Europe, USA and Asia etc.
-
Over 50,000 high quality brochures and flyers to be sent in 2007
-
Adverts in the top ten industry publications with your logo on them
OR
Call customer service on +65 6322 2700 to enquire!
|
